SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-24-001419
Filing Date
2024-08-13
Accepted
2024-08-13 16:13:54
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q g084352_10q.htm   iXBRL 10-Q 861785
2 EXHIBIT 31.1 g084352_ex31-1.htm EX-31.1 13300
3 EXHIBIT 31.2 g084352_ex31-2.htm EX-31.2 13195
4 EXHIBIT 32.1 g084352_ex32-1.htm EX-32.1 8250
5 EXHIBIT 32.2 g084352_ex32-2.htm EX-32.2 7772
  Complete submission text file 0001753926-24-001419.txt   4374574

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lipo-20240630.xsd EX-101.SCH 35512
7 XBRL CALCULATION FILE lipo-20240630_cal.xml EX-101.CAL 41102
8 XBRL DEFINITION FILE lipo-20240630_def.xml EX-101.DEF 93936
9 XBRL LABEL FILE lipo-20240630_lab.xml EX-101.LAB 264468
10 XBRL PRESENTATION FILE lipo-20240630_pre.xml EX-101.PRE 199955
68 EXTRACTED XBRL INSTANCE DOCUMENT g084352_10q_htm.xml XML 704873
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41575 | Film No.: 241201610
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)